News - Latest

1. MEB Science Day 2023: Biomarkers and Companion Diagnostics

   This year’s MEB Science Day focused on the future of precision medicine. The use of biomarkers and companion diagnostics plays an ...

   News item | 17-05-2023 | 15:00

2. On the move: MEB annual report 2022

   The Medicines Evaluation Board publishes its 2022 annual report today. We look on the year the Covid pandemic petered out. This ...

   News item | 12-04-2023 | 11:00

3. STARS: ‘A matter of bringing worlds together’

   June 2022 marked the finalisation of the three year period of STARS (Strengthening Training of Academia in Regulatory Science). ...

   News item | 20-03-2023 | 11:00

4. Restriction of possibilities for product information on the packaging of veterinary medicinal products

   Under the regulations before 28 January 2022, it was possible to include additional information on the packaging of a veterinary ...

   News item | 09-03-2023 | 09:00

5. MEB Science Day 2023: Register now!

   The Medicines Evaluation Board hosts the next edition of the MEB Science Day on 13 April 2023 themed ‘Biomarkers and Companion ...

   News item | 22-02-2023 | 14:00

6. Changes to fees for human medicinal products and devices as of 1 January 2023

   With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees for authorisation applications, ...

   News item | 02-01-2023 | 08:00

7. Registering the continued use of antimycotics or antiprotozoal veterinary medicinal products exclusively intended for specific companion animals

   Prior to the introduction of the  Veterinary Medicinal Products Regulation, antimycotics (antifungal agents) and antiprotozoal ...

   News item | 29-12-2022 | 12:15

8. Veterinary Medicinal Products Unit Fees for 2023 in revised Veterinary Medicinal Products Regulation 2022

   With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees. The fees of the Veterinary ...

   News item | 29-12-2022 | 12:00

9. New issue of Regulatory Science Magazine

   A significant portion of the potential anticancer medicines that reach the clinical phase do not make it to registration. This is ...

   News item | 07-12-2022 | 14:15

10. Amended procedure for sending, communicating and publishing letters and decisions

    The Veterinary Medicinal Products Unit has set in motion a number of changes to the sending, communicating and publishing letters ...

    News item | 06-10-2022 | 16:30